LMDXF — LumiraDx Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for LumiraDx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	171	139	159	132	100
Net Total Accounts Receivable
Net Total Receivables	23.7	27.6	119	104	65.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	200	180	377	406	267
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17.1	28.1	97.5	201	130
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	259	250	515	645	441
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	57.5	39.3	296	144	91.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	293	402	890	482	546
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-34.3	-153	-375	163	-105
Total Liabilities & Shareholders' Equity	259	250	515	645	441
Total Common Shares Outstanding